Status:
RECRUITING
High-throughput Serological Testing of Antibodies Platform
Lead Sponsor:
Istituto Zooprofilattico Sperimentale delle Venezie
Collaborating Sponsors:
European Union
VERDI Consortium
Conditions:
Diagnostics
Pandemic Response
Eligibility:
All Genders
2-65 years
Brief Summary
In the case of large emergency serosurveys, innovation in the sampling techniques is an often neglected, but relevant aspect to facilitate the enrolment of subjects in both adult and paediatric popula...
Detailed Description
Orthomyxoviridae, Flaviviridae, and Coronaviridae are viral families from which a pandemic/epidemic agent is expected to emerge in the coming years. In particular, highly pathogenic avian influenza vi...
Eligibility Criteria
Inclusion
- Adult Cohort - between 20 and 65 years of age Pediatric Cohort - between 2 and 10 years of age Signed consent form by the subject for adults or by caregivers for children
Exclusion
- subjects with an immunocompromised status, such as immunodeficiency disorders or those undergoing immunosuppressant treatments
- subjects with underlying chronic inflammatory conditions (i.e., autoimmune disorders, chronic gastrointestinal, and rheumatic conditions)
- subjects who have received immunomodulatory treatment within the past year.
Key Trial Info
Start Date :
April 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT06939556
Start Date
April 15 2025
End Date
October 31 2025
Last Update
June 8 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Zooprofilattico Sperimentale delle Venezie
Padua, Italy, Italy, 35020
2
Padova University Hospital, Department of Women's and Children's Health
Padua, Italy, Italy, 35128